Highmark Health, a Pittsburgh-based Blues plan, has reached a value-based drug-pricing contract with AstraZeneca for Symbicort, which is used to treat asthma and other chronic lung diseases.
A treatment that boosts the immune system greatly improved survival in people newly diagnosed with the most common form of lung cancer. It's the biggest win so far for immunotherapy, which has had much of its success in less common cancers.
The FDA's approval process for medical devices has been criticized for years for failing to catch problems with defective implants.
Google researchers announced that their new artificial intelligence algorithm can predict heart disease by scanning the patient's eye.